Proteotranscriptomic profiling of 231-BR breast cancer cells: Identification of potential biomarkers and therapeutic targets for brain metastasis

Molecular and Cellular Proteomics

Volumn 14, Issue 9, 2015, Pages 2316-2330

  Dun, Matthew D ^a,b   Chalkley, Robert J ^c   Faulkner, Sam ^a,b   Keene, Sheridan ^a,b   Avery Kiejda, Kelly A ^a,b   Scott, Rodney J ^a,b   Falkenby, Lasse G ^a,b   Cairns, Murray J ^d   Larsen, Martin R ^a,b   Bradshaw, Ralph A ^d   Hondermarck, Hubert ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Faculty of health and medicine; University of newcastle

Indexed keywords

BIOLOGICAL MARKER; CALVASCULIN; EPHRIN B1; INTERSTITIAL COLLAGENASE; L PLASTIN; MESSENGER RNA; MICRORNA; MYC TARGET 1 PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEOME; STOMATIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; TUMOR MARKER;

ARTICLE; BRAIN METASTASIS; BREAST CANCER CELL LINE; CELL CYCLE; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIQUID CHROMATOGRAPHY; METABOLISM; PRIORITY JOURNAL; PROTEOMICS; TANDEM MASS SPECTROMETRY; TRANSCRIPTOMICS; UPREGULATION; BRAIN TUMOR; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MASS SPECTROMETRY; MORTALITY; PROCEDURES; SECONDARY; TUMOR CELL LINE;

BIOMARKERS, TUMOR; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MASS SPECTROMETRY; PROTEOMICS; RNA, MESSENGER;

EID: 84940535687     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.046110     Document Type: Article

References (77)

1. Nayak, L., Lee, E. Q., and Wen, P. Y. (2012) Epidemiology of brain metastases. Curr. Oncol. Reports 14, 48-54
2. Eichler, A. F., Chung, E., Kodack, D. P., Loeffler, J. S., Fukumura, D., and Jain, R. K. (2011) The biology of brain metastases-translation to new therapies. Nature Rev. Clin. Oncol. 8, 344-356
3. Seoane, J., and De Mattos-Arruda, L. (2014) Brain metastasis: New opportunities to tackle therapeutic resistance. Mol. Oncol. 8, 1120-1131
4. Palmieri, D., Smith, Q. R., Lockman, P. R., Bronder, J., Gril, B., Chambers, A. F., Weil, R. J., and Steeg, P. S. (2006) Brain metastases of breast cancer. Breast Disease 26, 139-147
5. Eckhardt, B. L., Francis, P. A., Parker, B. S., and Anderson, R. L. (2012) Strategies for the discovery and development of therapies for metastatic breast cancer. Nat. Rev. Drug Discov. 11, 479-497
6. Yoneda, T., Williams, P. J., Hiraga, T., Niewolna, M., and Nishimura, R. (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J. Bone Miner. Res. 16, 1486-1495
7. Palmieri, D., Bronder, J. L., Herring, J. M., Yoneda, T., Weil, R. J., Stark, A. M., Kurek, R., Vega-Valle, E., Feigenbaum, L., Halverson, D., Vortmeyer, A. O., Steinberg, S. M., Aldape, K., and Steeg, P. S. (2007) Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res. 67, 4190-4198
8. Gril, B., Palmieri, D., Bronder, J. L., Herring, J. M., Vega-Valle, E., Feigenbaum, L., Liewehr, D. J., Steinberg, S. M., Merino, M. J., Rubin, S. D., and Steeg, P. S. (2008) Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J. Nat. Cancer Inst. 100, 1092-1103
9. Lockman, P. R., Mittapalli, R. K., Taskar, K. S., Rudraraju, V., Gril, B., Bohn, K. A., Adkins, C. E., Roberts, A., Thorsheim, H. R., Gaasch, J. A., Huang, S., Palmieri, D., Steeg, P. S., and Smith, Q. R. (2010) Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin. Cancer Res. 16, 5664-5678
10. Percy, D. B., Ribot, E. J., Chen, Y., McFadden, C., Simedrea, C., Steeg, P. S., Chambers, A. F., and Foster, P. J. (2011) In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach. Invest. Radiol. 46, 718-725
11. Fitzgerald, D. P., Subramanian, P., Deshpande, M., Graves, C., Gordon, I., Qian, Y., Snitkovsky, Y., Liewehr, D. J., Steinberg, S. M., Paltan-Ortiz, J. D., Herman, M. M., Camphausen, K., Palmieri, D., Becerra, S. P., and Steeg, P. S. (2012) Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: Implication for brain metastasis and metastasis-induced brain damage. Cancer Res. 72, 144-153
12. Li, F., Glinskii, O. V., Zhou, J., Wilson, L. S., Barnes, S., Anthony, D. C., and Glinsky, V. V. (2011) Identification and analysis of signaling networks potentially involved in breast carcinoma metastasis to the brain. PloS One 6, e21977
13. Fujiki, Y., Hubbard, A. L., Fowler, S., and Lazarow, P. B. (1982) Isolation of intracellular membranes by means of sodium carbonate treatment: Application to endoplasmic reticulum. J. Cell Biol. 93, 97-102
14. Larsen, M. R., Cordwell, S. J., and Roepstorff, P. (2002) Graphite powder as an alternative or supplement to reversed-phase material for desalting and concentration of peptide mixtures prior to matrix-assisted laser desorption/ionization-mass spectrometry. Proteomics 2, 1277-1287
15. Chalkley, R. J., Baker, P. R., Medzihradszky, K. F., Lynn, A. J., and Burlingame, A. L. (2008) In-depth analysis of tandem mass spectrometry data from disparate instrument types. Mol. Cell. Proteomics 7, 2386-2398
16. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214
17. Baker, P. R., and Chalkley, R. J. (2014) MS-viewer: A web-based spectral viewer for proteomics results. Mol. Cell. Proteomics 13, 1392-1396
18. Gallien, S., Duriez, E., Crone, C., Kellmann, M., Moehring, T., and Domon, B. (2012) Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Mol. Cell. Proteomics 11, 1709-1723
19. MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., and MacCoss, M. J. (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966-968
20. Friedman, R. C., Farh, K. K., Burge, C. B., and Bartel, D. P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105
21. Yang, J. H., Li, J. H., Shao, P., Zhou, H., Chen, Y. Q., and Qu, L. H. (2011) starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 39, D202-D209
22. Avery-Kiejda, K. A., Braye, S. G., Mathe, A., Forbes, J. F., and Scott, R. J. (2014) Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer. BMC Cancer 14, 51
23. Terp, M. G., Lund, R. R., Jensen, O. N., Leth-Larsen, R., and Ditzel, H. J. (2012) Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics. Cancer Genomics Proteomics 9, 265-273
24. Leth-Larsen, R., Lund, R., Hansen, H. V., Laenkholm, A. V., Tarin, D., Jensen, O. N., and Ditzel, H. J. (2009) Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol. Cell. Proteomics 8, 1436-1449
25. Geiger, T., Madden, S. F., Gallagher, W. M., Cox, J., and Mann, M. (2012) Proteomic portrait of human breast cancer progression identifies novel prognostic markers. Cancer Res. 72, 2428-2439
26. Ho, J., Kong, J. W., Choong, L. Y., Loh, M. C., Toy, W., Chong, P. K., Wong, C. H., Wong, C. Y., Shah, N., and Lim, Y. P. (2009) Novel breast cancer metastasis-associated proteins. J. Proteome Res. 8, 583-594
27. Kulasingam, V., and Diamandis, E. P. (2007) Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol. Cell. Proteomics 6, 1997-2011
28. Paget, S. (1989) The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 8, 98-101
29. Pienta, K. J., Robertson, B. A., Coffey, D. S., and Taichman, R. S. (2013) The cancer diaspora: Metastasis beyond the seed and soil hypothesis. Clin. Cancer Res. 19, 5849-5855
30. Gygi, S. P., Rochon, Y., Franza, B. R., and Aebersold, R. (1999) Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19, 1720-1730
31. Vogel, C., and Marcotte, E. M. (2012) Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227-232
32. Dawson, S. J., Rueda, O. M., Aparicio, S., and Caldas, C. (2013) A new genome-driven integrated classification of breast cancer and its implications. EMBO J. 32, 617-628
33. Rodriguez-Martinez, G., and Velasco, I. (2012) Activin and TGF-beta effects on brain development and neural stem cells. CNS Neurol. Disord. Drug Targets 11, 844-855
34. Yamasaki, S., Yagishita, N., Sasaki, T., Nakazawa, M., Kato, Y., Yamadera, T., Bae, E., Toriyama, S., Ikeda, R., Zhang, L., Fujitani, K., Yoo, E., Tsuchimochi, K., Ohta, T., Araya, N., Fujita, H., Aratani, S., Eguchi, K., Komiya, S., Maruyama, I., Higashi, N., Sato, M., Senoo, H., Ochi, T., Yokoyama, S., Amano, T., Kim, J., Gay, S., Fukamizu, A., Nishioka, K., Tanaka, K., and Nakajima, T. (2007) Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J. 26, 113-122
35. Wang, X., Lin, C., Zhao, X., Liu, A., Zhu, J., Li, X., and Song, L. (2014) Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Mol. Cancer 13, 106
36. Shats, I., Gatza, M. L., Liu, B., Angus, S. P., You, L., and Nevins, J. R. (2013) FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function. Cancer Res. 73, 6056-6067
37. Asiedu, M. K., Ingle, J. N., Behrens, M. D., Radisky, D. C., and Knutson, K. L. (2011) TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res. 71, 4707-4719
38. Yu, M., Zhou, X., Niu, L., Lin, G., Huang, J., Zhou, W., Gan, H., Wang, J., Jiang, X., Yin, B., and Li, Z. (2013) Targeting transmembrane TNF-alpha suppresses breast cancer growth. Cancer Res. 73, 4061-4074
39. Blair, L. P., Cao, J., Zou, M. R., Sayegh, J., and Yan, Q. (2011) Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer. Cancers 3, 1383-1404
40. Rasmussen, P. B., and Staller, P. (2014) The KDM5 family of histone demethylases as targets in oncology drug discovery. Epigenomics 6, 277-286
41. Simmons, K. M., Beaudin, S. G., Narvaez, C. J., and Welsh, J. (2015) Gene Signatures of 1,25-Dihydroxyvitamin D Exposure in Normal and Transformed Mammary Cells. J. Cell. Biochem. 116, 1693-1711
42. Imamura, T., Hikita, A., and Inoue, Y. (2012) The roles of TGF-beta signaling in carcinogenesis and breast cancer metastasis. Breast Cancer 19, 118-124
43. Yang, Y., Feng, R., Bi, S., and Xu, Y. (2011) TNF-alpha polymorphisms and breast cancer. Breast Cancer Res. Treat. 129, 513-519
44. Hadler-Olsen, E., Winberg, J. O., and Uhlin-Hansen, L. (2013) Matrix metalloproteinases in cancer: Their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol. 34, 2041-2051
45. McGowan, P. M., and Duffy, M. J. (2008) Matrix metalloproteinase expression and outcome in patients with breast cancer: Analysis of a published database. Ann. Oncol. 19, 1566-1572
46. Liu, H., Kato, Y., Erzinger, S. A., Kiriakova, G. M., Qian, Y., Palmieri, D., Steeg, P. S., and Price, J. E. (2012) The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model. BMC Cancer 12, 583
47. Zhou, Y., Cui, Z., Xia, X., Liu, C., Zhu, X., Cao, J., Wu, Y., Zhou, L., Ben, Z., Song, Y., Zhang, H., and Zhang, D. (2014) Matrix metalloproteinase-1 (MMP-1) expression in rat spinal cord injury model. Cell. Mol. Neurobiol. 34, 1151-1163
48. Coussens, L. M., Fingleton, B., and Matrisian, L. M. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392
49. Lia, N. G., Shib, Z. H., Tang, Y. P., and Duan, J. A. (2009) Selective matrix metalloproteinase inhibitors for cancer. Curr. Med. Chem. 16, 3805-3827
50. Pasquale, E. B. (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133, 38-52
51. Kaenel, P., Mosimann, M., and Andres, A. C. (2012) The multifaceted roles of Eph/ephrin signaling in breast cancer. Cell Adhesion Migration 6, 138-147
52. Yin, H., Lu, C., Tang, Y., Wang, H., Wang, H., and Wang, J. (2013) Enhanced expression of EphrinB1 is associated with lymph node metastasis and poor prognosis in breast cancer. Cancer Biomarkers 13, 261-267
53. Vermeer, P. D., Bell, M., Lee, K., Vermeer, D. W., Wieking, B. G., Bilal, E., Bhanot, G., Drapkin, R. I., Ganesan, S., Klingelhutz, A. J., Hendriks, W. J., and Lee, J. H. (2012) ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers. PloS One 7, e30447
54. Yang, S., Li, Y., Gao, J., Zhang, T., Li, S., Luo, A., Chen, H., Ding, F., Wang, X., and Liu, Z. (2013) MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene 32, 4294-4303
55. Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Korner, H., Knyazev, P., Diebold, J., and Hermeking, H. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7, 2591-2600
56. Noberini, R., Lamberto, I., and Pasquale, E. B. (2012) Targeting Eph receptors with peptides and small molecules: progress and challenges. Semin. Cell Dev. Biol. 23, 51-57
57. Lapatsina, L., Brand, J., Poole, K., Daumke, O., and Lewin, G. R. (2012) Stomatin-domain proteins. Eur. J. Cell Biol. 91, 240-245
58. Mio, T., Yabe, T., Arisawa, M., and Yamada-Okabe, H. (1998) The eukaryotic UDP-N-acetylglucosamine pyrophosphorylases. Gene cloning, protein expression, and catalytic mechanism. J. Biol. Chem. 273, 14392-14397
59. Yip, G. W., Smollich, M., and Gotte, M. (2006) Therapeutic value of glycosaminoglycans in cancer. Mol. Cancer Ther. 5, 2139-2148
60. Bos, P. D., Zhang, X. H., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., and Massague, J. (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005-1009
61. Rogulski, K. R., Cohen, D. E., Corcoran, D. L., Benos, P. V., and Prochownik, E. V. (2005) Deregulation of common genes by c-Myc and its direct target, MT-MC1. Proc. Natl. Acad. Sci. U.S.A. 102, 18968-18973
62. Cohen, D. E., and Prochownik, E. V. (2006) A functional hierarchy for c-Myc target genes? Lessons from MT-MC1. Cell Cycle 5, 392-393
63. Lai, T. S., and Greenberg, C. S. (2013) TGM2 and implications for human disease: Role of alternative splicing. Frontiers Biosci. 18, 504-519
64. Brown, K. D. (2013) Transglutaminase 2 and NF-kappaB: An odd couple that shapes breast cancer phenotype. Breast Cancer Res. Treat. 137, 329-336
65. Akimov, S. S., Krylov, D., Fleischman, L. F., and Belkin, A. M. (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J. Cell Biol. 148, 825-838
66. Hang, J., Zemskov, E. A., Lorand, L., and Belkin, A. M. (2005) Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase. J. Biol. Chem. 280, 23675-23683
67. Greenberg, C. S., Birckbichler, P. J., and Rice, R. H. (1991) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5, 3071-3077
68. Boye, K., and Maelandsmo, G. M. (2010) S100A4 and metastasis: A small actor playing many roles. Am. J. Pathol. 176, 528-535
69. Mishra, S. K., Siddique, H. R., and Saleem, M. (2012) S100A4 calciumbinding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev. 31, 163-172
70. Kozlova, E. N., and Lukanidin, E. (2002) Mts1 protein expression in the central nervous system after injury. Glia 37, 337-348
71. Dmytriyeva, O., Pankratova, S., Owczarek, S., Sonn, K., Soroka, V., Ridley, C. M., Marsolais, A., Lopez-Hoyos, M., Ambartsumian, N., Lukanidin, E., Bock, E., Berezin, V., and Kiryushko, D. (2012) The metastasis-promoting S100A4 protein confers neuroprotection in brain injury. Nat. Commun. 3, 1197
72. Al Tanoury, Z., Schaffner-Reckinger, E., Halavatyi, A., Hoffmann, C., Moes, M., Hadzic, E., Catillon, M., Yatskou, M., and Friederich, E. (2010) Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over. PloS One 5, e9210
73. Riplinger, S. M., Wabnitz, G. H., Kirchgessner, H., Jahraus, B., Lasitschka, F., Schulte, B., van der Pluijm, G., van der Horst, G., Hammerling, G. J., Nakchbandi, I., and Samstag, Y. (2014) Metastasis of prostate cancer and melanoma cells in a preclinical in vivo mouse model is enhanced by L-plastin expression and phosphorylation. Mol. Cancer 13, 10
74. Cancer Genome Atlas Research Network, N., Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., and Stuart, J. M. (2013) The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113-1120
75. Faulkner, S., Dun, M. D., and Hondermarck, H. (2015) Proteogenomics: emergence and promise. Cell Mol. Life Sci. 72, 953-957
76. Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M. C., Zimmerman, L. J., Shaddox, K. F., Kim, S., Davies, S. R., Wang, S., Wang, P., Kinsinger, C. R., Rivers, R. C., Rodriguez, H., Townsend, R. R., Ellis, M. J., Carr, S. A., Tabb, D. L., Coffey, R. J., Slebos, R. J., Liebler, D. C., and Nci, C. (2014) Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382-387
77. Falkenby, L. G., Such-Sanmartín, G., Larsen, M. R., Vorm, O., Bache, N., Jensen, O. N. (2014) Integrated solid-phase extraction-capillary liquid chromatography (speLC) interfaced to ESI-MS/MS for fast characterization and quantification of protein and proteomes. J Proteome Res. 13, 6169-6175